Garcia-Alvarez A, Regueiro A, Hernández J, Kasa G, Sitges M, Bosch X, Heras M
Eur Heart J Acute Cardiovasc Care. 2014 Jun;3(2):132-40, PMID: 24448752
Few studies have addressed the additional value of B-type natriuretic peptide (BNP) on risk stratification in non-ST-elevation acute coronary syndrome (NSTE-ACS). We aimed to evaluate whether BNP levels provide additional improvement on discrimination and reclassification of patients at risk of mortality during admission and follow up after a NSTE-ACS.